Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
J Allergy Clin Immunol Pract
; 12(1): 212-222, 2024 01.
Article
in En
| MEDLINE
| ID: mdl-37844846
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angioedemas, Hereditary
/
Angioedema
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Allergy Clin Immunol Pract
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos